Healthcare & Life Sciences
Beacon Therapeutics
United Statesbeacontx.com
Beacon Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 2 tracked investors.
activeseries-c-plus
series-c-plus
Stage
2
Investors
About Beacon Therapeutics
Beacon Therapeutics is a startup based in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Beacon Therapeutics is an ophthalmic gene therapy company developing AAV-based treatments to restore and improve vision for patients with inherited and other retinal diseases. Its lead asset, AGTC-501 (laru-zova), is in Phase III clinical trials for X-linked retinitis pigmentosa (XLRP).
Explore Beacon Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.